Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 24, 2017
Pharmacy Choice - Pharmaceutical News - Global $228.8 Billion Generic Drugs Market 2017-2022 - Key Players are Freseunis, Hospira, Mylan, Novartis, Sandoz & Teva Pharmaceuticals - Research and Markets - July 24, 2017

Pharmacy News Article

 4/20/17 - Global $228.8 Billion Generic Drugs Market 2017-2022 - Key Players are Freseunis, Hospira, Mylan, Novartis, Sandoz & Teva Pharmaceuticals - Research and Markets

DUBLIN(BUSINESS WIRE) Research and Markets has announced the addition of the "Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report to their offering.

The global generic drugs market was valued at around US$ 228.8 Billion in 2016, growing at a CAGR of around 9% during 2010-2016

The biggest catalyst for growth is an increasing global pharmaceutical spending trend towards generics. Continuously increasing healthcare expenditures have pushed governments and third-party payers to seek ways to control their healthcare expenditures. This is catalyzing an increasing demand for generics versus their branded counterparts. Another major driver of this industry is the continued patent cliff that is providing growing pipelines opportunities for generic firms. Similarly, a growth in the overall global population and aging demographics is also proving to be beneficial for the overall healthcare sector including generic drug manufacturers. Healthcare reforms in the US and other developed markets coupled with strong growth in emerging market are some other important drivers for the generic drugs market.

Key Topics Covered:

1 Preface

2 Research Methodology

3 Executive Summary

4 Introduction

5 Global Generic Drug Industry

6 Performance of Key Regions

7 Competitive Landscape

8 Generic Drug Manufacturing Process

9 Project Details, Requirements and Costs Involved

10 Loans and Financial Assistance

11 Project Economics

Companies Mentioned

  • Freseunis
  • Hospira
  • Mylan
  • Novartis - Sandoz
  • Teva Pharmaceuticals

For more information about this report visit http://www.researchandmarkets.com/research/b6lxt6/generic-drugs

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Topics: Generic Drugs

Source: Research and Markets



Copyright Business Wire 2017

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Jul 24: What's New? New Treatments for Type 2 Diabetes
Jul 26: Management of Schizophrenia & Acute Agitation
Jul 27: On the Move: A Comprehensive Review of Osteoarthritis, Gout & Rheumatoid Arthritis
Jul 31: Obesity Management: Overview of Pharmacotherapy
Aug 01: Treatment of Depression and Anxiety in Older Adults
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415